Filing Flows

Filing Flows › Biodesix (BDSX) › Who owns the stock

Who owns Biodesix (BDSX) stock

44 funds reported Biodesix (BDSX) shares in their latest 13F filings, worth $101M in all. The largest holder is Aigh Capital Management LLC ($20.5M). Last quarter 24 funds added to their stakes and 17 cut them.

Largest holders of BDSX (13F)Largest holders of BDSX (13F)Aigh Capital Management LLC$20.5MSoleus Capital Management, L.P.$13.2MTelemark Asset Management, LLC$11.0Mabrdn$8.8MEssex Investment Management Co LLC$7.0MVanguard Capital Management LLC$6.4MOpaleye Management$4.1MMarshall Wace, LLP$2.6MPerceptive Advisors LLC$2.5MJane Street Group, LLC$2.1M

Largest holders (13F)

FundSharesValueChangeQuarter
Aigh Capital Management LLC686,021$20.5Mincrease2026-09-30
Soleus Capital Management, L.P.585,958$13.2Mincrease2026-06-30
Telemark Asset Management, LLC489,824$11.0Munchanged2026-06-30
abrdn388,639$8.8Mdecrease2026-06-30
Essex Investment Management Co LLC234,542$7.0Mdecrease2026-09-30
Vanguard Capital Management LLC284,169$6.4Mincrease2026-06-30
Opaleye Management180,000$4.1Mdecrease2026-06-30
Marshall Wace, LLP116,199$2.6Mdecrease2026-06-30
Perceptive Advisors LLC108,694$2.5Mnew2026-06-30
Jane Street Group, LLC91,506$2.1Mincrease2026-06-30
Two Sigma Investments, LP86,824$2.0Mincrease2026-06-30
Legato Capital Management LLC81,381$1.8Mincrease2026-06-30
Perkins Capital Management61,335$1.8Mincrease2026-09-30
Walleye Capital LLC74,447$1.7Mincrease2026-06-30
Stempoint Capital LP70,000$1.6Mdecrease2026-06-30

Biodesix's latest quarter

Biodesix, Q3 2026: revenue $24.0M (+10% year over year), operating margin -25.4%, net loss $8.0M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most BDSX stock?

By the latest 13F filings: Aigh Capital Management LLC ($20.5M); Soleus Capital Management, L.P. ($13.2M); Telemark Asset Management, LLC ($11.0M); abrdn ($8.8M); Essex Investment Management Co LLC ($7.0M).

What is the short interest in BDSX?

209,504 shares were sold short at the 2026-10-15 settlement, 3.79% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.